Osaic Holdings
TEVA icon

Osaic Holdings’s Teva Pharmaceuticals TEVA Stock Holding History

Osaic Holdings’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-120
Closed -$8K – 6946
2020
Q4 		$8K Buy
+120
New +$1.15K ﹤0.01% 5614

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Osaic Holdings's TEVA Position: Q1 2026 in Review

Osaic Holdings reduced its Teva Pharmaceuticals (TEVA) stake by 8.6% in Q1 2026, selling an estimated $244K and leaving 80,772 shares worth $2.43M. The position accounts for ﹤0.01% of the portfolio, ranked #1920.

Osaic Holdings first reported a position in TEVA in Q1 2020 and has held it in 25 quarters since. The position peaked at $2.76M in Q4 2025. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Osaic Holdings held 80,772 shares of Teva Pharmaceuticals worth $2.43M as of Q1 2026.
  • Osaic Holdings sold 7,578 Teva Pharmaceuticals shares in Q1 2026, an estimated $244K.
  • Teva Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #1920 holding.
  • Osaic Holdings first reported a position in Teva Pharmaceuticals in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Teva Pharmaceuticals position peaked at $2.76M in Q4 2025.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.